U.S. Opioid and Non-Opioid Pain Management Pharmaceuticals MarketsFrost & SullivanFebruary 26, 2007 87 Pages - SKU: MC1472004 |
| Countries covered: United States This Frost & Sullivan research service titled U.S. Opioid and Non-opioid Pain Management Pharmaceuticals Markets provides a detailed analysis of the competitive structure, market forecasts, and market share. In this study, Frost & Sullivan's expert analysts thoroughly examine the following markets: Opioid and non-opioid pain management pharmaceuticals. Market Overview Partnerships between Specialty Pharmaceutical and Drug Delivery Companies to Help Improve Therapies for Opioid and Non-Opioid Pain Management The significant recall of Vioxx and Bextra from the market, coupled with the robust demand for pain management therapies, is creating substantial opportunities for novel therapies in the U.S. opioid and non-opioid pain management markets. Despite the lack of major breakthrough therapies, specialty pharma and drug delivery companies have successfully engaged in lifecycle management partnerships to relaunch older therapies in newer formulations to cater to the swelling demand. "A rapidly ageing population is substantially driving the need for effective pain management therapies for acute and chronic pain," says the analyst of this research service. "There is considerable unmet medical need in the treatment of pain and newer and more effective therapies will be welcome in this market." Noting the remarkable market potential, several "Big Pharma", specialty pharmaceutical, and drug delivery companies have been planning to expand their market presence, thereby driving market growth. Drug Delivery Companies to Promote Abuse-proof Formulations to Gain Wider Customer Acceptance and Meet Regulatory Norms There have been increasing apprehensions regarding the safety profile of opioid and non-opioid therapies. The escalating regulatory and media scrutiny on opioid therapies have compelled drug companies to address the issue of potential drug abuse. "The collaborations between pharmaceuticals and drug delivery companies have ensured that next-generation drugs have abuse- and tamper-resistant formulations," notes the analyst. Market participants can promote this benefit to not only expand their customer base but also meet the increasingly stringent regulatory norms. |
More United States Prescription Drugs Reports
2012 Healthcare Business Market Research Handbook by
Richard K. Miller & Associates
The 2012 Healthcare Business Market Research Handbook presents a comprehensive analysis of the $2.8 trillion U.S. healthcare marketplace with the most recent statistics and data ...
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report by
IBISWorld
Brand Name Pharmaceutical Manufacturing in the US Prescription for growth With healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience ...
Analysis of the United States Contract Manufacturing Outsourcing Market by
Frost & Sullivan
Contract manufacturing outsourcing (CMO) companies provide independent manufacturing services for pharmaceutical and biotechnological markets. This study covers the U.S. commercial manufacturing and packaging of pharmaceutical ...
United States Pharmaceuticals and Healthcare Report Q2 2012 by
Business Monitor International
BMI View: Economics and politics are increasingly exerting an influence on the US pharmaceuticalmarket. This is in stark contrast to the late 1990s and early ...
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment by
AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
Prescription Drugs Reports
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Chinese Markets for Hepatitis Drugs
- Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
